nodes	percent_of_prediction	percent_of_DWPC	metapath
Bismuth Subsalicylate—ALB—hepatitis B	0.731	1	CbGaD
Bismuth Subsalicylate—TF—semen—hepatitis B	0.0397	0.356	CbGeAlD
Bismuth Subsalicylate—TF—saliva—hepatitis B	0.0332	0.298	CbGeAlD
Bismuth Subsalicylate—TF—blood plasma—hepatitis B	0.0145	0.13	CbGeAlD
Bismuth Subsalicylate—TF—blood—hepatitis B	0.0053	0.0475	CbGeAlD
Bismuth Subsalicylate—PTGS1—blood plasma—hepatitis B	0.00429	0.0384	CbGeAlD
Bismuth Subsalicylate—TF—liver—hepatitis B	0.00414	0.0371	CbGeAlD
Bismuth Subsalicylate—PTGS2—blood plasma—hepatitis B	0.0041	0.0367	CbGeAlD
Bismuth Subsalicylate—Abdominal pain upper—Entecavir—hepatitis B	0.00389	0.0386	CcSEcCtD
Bismuth Subsalicylate—Abdominal pain upper—Telbivudine—hepatitis B	0.0032	0.0317	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Entecavir—hepatitis B	0.00295	0.0293	CcSEcCtD
Bismuth Subsalicylate—Abdominal discomfort—Telbivudine—hepatitis B	0.0029	0.0288	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00288	0.0286	CcSEcCtD
Bismuth Subsalicylate—Hearing impaired—Lamivudine—hepatitis B	0.00285	0.0283	CcSEcCtD
Bismuth Subsalicylate—TF—HIF-1-alpha transcription factor network—HNF4A—hepatitis B	0.00252	0.0444	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Scavenging of heme from plasma—HP—hepatitis B	0.00251	0.0443	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Eicosanoid Synthesis—GGT2—hepatitis B	0.00249	0.0439	CbGpPWpGaD
Bismuth Subsalicylate—Hepatitis—Telbivudine—hepatitis B	0.00242	0.024	CcSEcCtD
Bismuth Subsalicylate—Phlebitis—Lamivudine—hepatitis B	0.00229	0.0227	CcSEcCtD
Bismuth Subsalicylate—Deafness—Lamivudine—hepatitis B	0.0022	0.0219	CcSEcCtD
Bismuth Subsalicylate—ALB—liver—hepatitis B	0.00215	0.0193	CbGeAlD
Bismuth Subsalicylate—Infection—Entecavir—hepatitis B	0.00208	0.0207	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Telbivudine—hepatitis B	0.00206	0.0205	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Eicosanoid Synthesis—GGT2—hepatitis B	0.00197	0.0349	CbGpPWpGaD
Bismuth Subsalicylate—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00195	0.0193	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet degranulation—HSPA5—hepatitis B	0.00188	0.0331	CbGpPWpGaD
Bismuth Subsalicylate—Somnolence—Entecavir—hepatitis B	0.00186	0.0185	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Entecavir—hepatitis B	0.00184	0.0183	CcSEcCtD
Bismuth Subsalicylate—Abdominal pain upper—Lamivudine—hepatitis B	0.0018	0.0179	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.0018	0.0179	CcSEcCtD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—HSPA5—hepatitis B	0.00179	0.0316	CbGpPWpGaD
Bismuth Subsalicylate—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00178	0.0176	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Entecavir—hepatitis B	0.00166	0.0164	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—CYP2A6—hepatitis B	0.00165	0.0292	CbGpPWpGaD
Bismuth Subsalicylate—Abdominal discomfort—Lamivudine—hepatitis B	0.00163	0.0162	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00161	0.016	CcSEcCtD
Bismuth Subsalicylate—PTGS1—blood—hepatitis B	0.00157	0.0141	CbGeAlD
Bismuth Subsalicylate—Dyspepsia—Telbivudine—hepatitis B	0.00151	0.015	CcSEcCtD
Bismuth Subsalicylate—PTGS2—blood—hepatitis B	0.0015	0.0135	CbGeAlD
Bismuth Subsalicylate—Pain—Telbivudine—hepatitis B	0.00147	0.0146	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00145	0.0144	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Lamivudine—hepatitis B	0.00143	0.0142	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Entecavir—hepatitis B	0.00143	0.0142	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Telbivudine—hepatitis B	0.00142	0.0141	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.0014	0.0139	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Entecavir—hepatitis B	0.00138	0.0138	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Lamivudine—hepatitis B	0.00136	0.0136	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Telbivudine—hepatitis B	0.00136	0.0135	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Entecavir—hepatitis B	0.00133	0.0132	CcSEcCtD
Bismuth Subsalicylate—Rash—Entecavir—hepatitis B	0.00132	0.0131	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Entecavir—hepatitis B	0.00132	0.0131	CcSEcCtD
Bismuth Subsalicylate—Headache—Entecavir—hepatitis B	0.00131	0.013	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Adefovir Dipivoxil—hepatitis B	0.0013	0.0129	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Lamivudine—hepatitis B	0.00129	0.0128	CcSEcCtD
Bismuth Subsalicylate—Rash—Adefovir Dipivoxil—hepatitis B	0.00129	0.0128	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00129	0.0128	CcSEcCtD
Bismuth Subsalicylate—Headache—Adefovir Dipivoxil—hepatitis B	0.00128	0.0127	CcSEcCtD
Bismuth Subsalicylate—Nausea—Entecavir—hepatitis B	0.00124	0.0124	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—HBE1—hepatitis B	0.00124	0.0219	CbGpPWpGaD
Bismuth Subsalicylate—Pruritus—Telbivudine—hepatitis B	0.00122	0.0121	CcSEcCtD
Bismuth Subsalicylate—Nausea—Adefovir Dipivoxil—hepatitis B	0.00121	0.0121	CcSEcCtD
Bismuth Subsalicylate—Erythema—Lamivudine—hepatitis B	0.00119	0.0118	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Telbivudine—hepatitis B	0.00118	0.0117	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Eicosanoid Synthesis—GGT1—hepatitis B	0.00118	0.0208	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—liver—hepatitis B	0.00117	0.0105	CbGeAlD
Bismuth Subsalicylate—TF—HIF-1-alpha transcription factor network—NOS2—hepatitis B	0.00117	0.0206	CbGpPWpGaD
Bismuth Subsalicylate—Dysgeusia—Lamivudine—hepatitis B	0.00116	0.0116	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Telbivudine—hepatitis B	0.00114	0.0113	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Telbivudine—hepatitis B	0.00109	0.0109	CcSEcCtD
Bismuth Subsalicylate—Rash—Telbivudine—hepatitis B	0.00108	0.0108	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Telbivudine—hepatitis B	0.00108	0.0108	CcSEcCtD
Bismuth Subsalicylate—Headache—Telbivudine—hepatitis B	0.00108	0.0107	CcSEcCtD
Bismuth Subsalicylate—Nausea—Telbivudine—hepatitis B	0.00102	0.0101	CcSEcCtD
Bismuth Subsalicylate—ALB—Binding and Uptake of Ligands by Scavenger Receptors—HP—hepatitis B	0.001	0.0177	CbGpPWpGaD
Bismuth Subsalicylate—Confusional state—Lamivudine—hepatitis B	0.000977	0.00971	CcSEcCtD
Bismuth Subsalicylate—Oedema—Lamivudine—hepatitis B	0.000969	0.00963	CcSEcCtD
Bismuth Subsalicylate—Infection—Lamivudine—hepatitis B	0.000963	0.00956	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Eicosanoid Synthesis—GGT1—hepatitis B	0.000934	0.0165	CbGpPWpGaD
Bismuth Subsalicylate—Anorexia—Lamivudine—hepatitis B	0.000924	0.00918	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—GGT2—hepatitis B	0.00088	0.0155	CbGpPWpGaD
Bismuth Subsalicylate—Somnolence—Lamivudine—hepatitis B	0.000862	0.00856	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Lamivudine—hepatitis B	0.000853	0.00847	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Lamivudine—hepatitis B	0.000843	0.00837	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet degranulation—ALB—hepatitis B	0.000842	0.0149	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—HSPA5—hepatitis B	0.000832	0.0147	CbGpPWpGaD
Bismuth Subsalicylate—Constipation—Lamivudine—hepatitis B	0.000829	0.00823	CcSEcCtD
Bismuth Subsalicylate—Pain—Lamivudine—hepatitis B	0.000829	0.00823	CcSEcCtD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—ALB—hepatitis B	0.000802	0.0142	CbGpPWpGaD
Bismuth Subsalicylate—TF—Differentiation Pathway—TGFB1—hepatitis B	0.000801	0.0141	CbGpPWpGaD
Bismuth Subsalicylate—Feeling abnormal—Lamivudine—hepatitis B	0.000799	0.00793	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Lamivudine—hepatitis B	0.00077	0.00765	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Lamivudine—hepatitis B	0.000766	0.00761	CcSEcCtD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—IL10—hepatitis B	0.000766	0.0135	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—GGT2—hepatitis B	0.000698	0.0123	CbGpPWpGaD
Bismuth Subsalicylate—Pruritus—Lamivudine—hepatitis B	0.000686	0.00681	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Lamivudine—hepatitis B	0.000663	0.00659	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—hepatitis B	0.000663	0.0117	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Arachidonic acid metabolism—GGT1—hepatitis B	0.000654	0.0115	CbGpPWpGaD
Bismuth Subsalicylate—Dizziness—Lamivudine—hepatitis B	0.000641	0.00637	CcSEcCtD
Bismuth Subsalicylate—ALB—FOXA2 and FOXA3 transcription factor networks—HNF4A—hepatitis B	0.000634	0.0112	CbGpPWpGaD
Bismuth Subsalicylate—Vomiting—Lamivudine—hepatitis B	0.000616	0.00612	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—hepatitis B	0.000616	0.0109	CbGpPWpGaD
Bismuth Subsalicylate—Rash—Lamivudine—hepatitis B	0.000611	0.00607	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Lamivudine—hepatitis B	0.000611	0.00606	CcSEcCtD
Bismuth Subsalicylate—Headache—Lamivudine—hepatitis B	0.000607	0.00603	CcSEcCtD
Bismuth Subsalicylate—TF—Differentiation Pathway—IL6—hepatitis B	0.000604	0.0107	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000587	0.0104	CbGpPWpGaD
Bismuth Subsalicylate—Nausea—Lamivudine—hepatitis B	0.000576	0.00572	CcSEcCtD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—GGT2—hepatitis B	0.000565	0.00997	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet degranulation—TGFB1—hepatitis B	0.000533	0.0094	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—MIF—hepatitis B	0.000532	0.00939	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—hepatitis B	0.000522	0.00921	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Arachidonic acid metabolism—GGT1—hepatitis B	0.000519	0.00917	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Biological oxidations—GGT2—hepatitis B	0.000515	0.00909	CbGpPWpGaD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—TGFB1—hepatitis B	0.000507	0.00896	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—F2—hepatitis B	0.00045	0.00794	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Overview of nanoparticle effects—TNF—hepatitis B	0.000446	0.00787	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—hepatitis B	0.000437	0.00772	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—HSPA5—hepatitis B	0.000429	0.00757	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—hepatitis B	0.000429	0.00757	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—GGT1—hepatitis B	0.000416	0.00735	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—hepatitis B	0.000398	0.00703	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—hepatitis B	0.00039	0.00688	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—IFNB1—hepatitis B	0.000387	0.00683	CbGpPWpGaD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	0.000386	0.00682	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—IFNA1—hepatitis B	0.000377	0.00666	CbGpPWpGaD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—NFKB1—hepatitis B	0.000375	0.00662	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—ALB—hepatitis B	0.000373	0.00659	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Overview of nanoparticle effects—IL6—hepatitis B	0.00036	0.00635	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Overview of nanoparticle effects—TNF—hepatitis B	0.000354	0.00624	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—IFNA2—hepatitis B	0.000351	0.0062	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—hepatitis B	0.000346	0.00611	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet degranulation—HSPA5—hepatitis B	0.000342	0.00603	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—GGT1—hepatitis B	0.00033	0.00583	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—HSPA5—hepatitis B	0.000326	0.00575	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Biological oxidations—CYP2A6—hepatitis B	0.000312	0.0055	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—IL2—hepatitis B	0.000303	0.00535	CbGpPWpGaD
Bismuth Subsalicylate—ALB—FOXA2 and FOXA3 transcription factor networks—F2—hepatitis B	0.000298	0.00526	CbGpPWpGaD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—TNF—hepatitis B	0.000291	0.00515	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Overview of nanoparticle effects—IL6—hepatitis B	0.000285	0.00504	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—GGT1—hepatitis B	0.000267	0.00472	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—F2—hepatitis B	0.000266	0.0047	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—F2—hepatitis B	0.000265	0.00467	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—hepatitis B	0.000252	0.00445	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—CXCL10—hepatitis B	0.000251	0.00444	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Biological oxidations—GGT1—hepatitis B	0.000243	0.0043	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.000242	0.00427	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—TGFB1—hepatitis B	0.000236	0.00417	CbGpPWpGaD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—IL6—hepatitis B	0.000235	0.00415	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—F2—hepatitis B	0.000232	0.00409	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—NOS2—hepatitis B	0.000229	0.00404	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—hepatitis B	0.000226	0.00399	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—HBE1—hepatitis B	0.000226	0.00398	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—hepatitis B	0.000224	0.00396	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—hepatitis B	0.000224	0.00395	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—ALB—hepatitis B	0.000221	0.00391	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—F2—hepatitis B	0.000215	0.0038	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—F2—hepatitis B	0.000212	0.00373	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000206	0.00364	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—IFNG—hepatitis B	0.000202	0.00357	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—IFNG—hepatitis B	0.000201	0.00354	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—ALB—hepatitis B	0.000192	0.0034	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—hepatitis B	0.000191	0.00338	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—ALB—hepatitis B	0.000176	0.0031	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—TNF—hepatitis B	0.000174	0.00308	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TLR4—hepatitis B	0.000174	0.00307	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—F2—hepatitis B	0.000171	0.00302	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—CDKN2A—hepatitis B	0.000171	0.00301	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—NFKB1—hepatitis B	0.000168	0.00297	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—NFKB1—hepatitis B	0.000167	0.00295	CbGpPWpGaD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—ALB—hepatitis B	0.000167	0.00294	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—NOS2—hepatitis B	0.000165	0.00292	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000164	0.00289	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—IFNG—hepatitis B	0.000163	0.00288	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—hepatitis B	0.000163	0.00288	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—CD4—hepatitis B	0.000161	0.00284	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—IFNG—hepatitis B	0.00016	0.00283	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—IL2—hepatitis B	0.000156	0.00276	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—HSPA5—hepatitis B	0.000152	0.00268	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—IL2—hepatitis B	0.000145	0.00256	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—CDKN1A—hepatitis B	0.000139	0.00246	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.000136	0.00241	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—NFKB1—hepatitis B	0.000136	0.0024	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—NFKB1—hepatitis B	0.000133	0.00236	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000132	0.00234	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.000131	0.00232	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—TNF—hepatitis B	0.000131	0.00231	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—TNF—hepatitis B	0.00013	0.00229	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—IFNG—hepatitis B	0.00013	0.00229	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—IFNG—hepatitis B	0.000127	0.00224	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—TGFB1—hepatitis B	0.000122	0.00215	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—IL2—hepatitis B	0.000113	0.00199	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—NFKB1—hepatitis B	0.000108	0.00191	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—TNF—hepatitis B	0.000106	0.00187	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—IL6—hepatitis B	0.000105	0.00186	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—IL6—hepatitis B	0.000105	0.00185	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—TNF—hepatitis B	0.000104	0.00183	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—TP53—hepatitis B	0.0001	0.00177	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet degranulation—TGFB1—hepatitis B	9.7e-05	0.00171	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—APOBEC3G—hepatitis B	9.62e-05	0.0017	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SAG—hepatitis B	9.62e-05	0.0017	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	9.35e-05	0.00165	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—TP53—hepatitis B	9.32e-05	0.00164	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—hepatitis B	9.24e-05	0.00163	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—AKR1B1—hepatitis B	9.18e-05	0.00162	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GGT2—hepatitis B	8.8e-05	0.00155	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TGFB1—hepatitis B	8.79e-05	0.00155	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—IL6—hepatitis B	8.53e-05	0.00151	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—TNF—hepatitis B	8.39e-05	0.00148	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—IL6—hepatitis B	8.37e-05	0.00148	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TNF—hepatitis B	8.21e-05	0.00145	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—F2—hepatitis B	8.19e-05	0.00145	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—HSPA5—hepatitis B	7.81e-05	0.00138	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	7.42e-05	0.00131	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	7.4e-05	0.00131	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—AKR1B1—hepatitis B	7.29e-05	0.00129	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TP53—hepatitis B	7.23e-05	0.00128	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	7.23e-05	0.00128	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	7.21e-05	0.00127	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	7.18e-05	0.00127	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—IFNB1—hepatitis B	7.05e-05	0.00124	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GGT2—hepatitis B	6.99e-05	0.00123	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—IFNA1—hepatitis B	6.88e-05	0.00121	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—IL6—hepatitis B	6.77e-05	0.0012	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—IL6—hepatitis B	6.62e-05	0.00117	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—IFNA2—hepatitis B	6.4e-05	0.00113	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	6e-05	0.00106	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	5.98e-05	0.00106	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—AKR1B1—hepatitis B	5.9e-05	0.00104	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GGT2—hepatitis B	5.65e-05	0.000998	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	5.58e-05	0.000986	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—IL2—hepatitis B	5.52e-05	0.000974	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CYP2A6—hepatitis B	5.33e-05	0.000941	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—ALB—hepatitis B	4.97e-05	0.000878	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	4.92e-05	0.000869	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GOT2—hepatitis B	4.82e-05	0.000851	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—GOT2—hepatitis B	4.57e-05	0.000807	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—TGFB1—hepatitis B	4.3e-05	0.00076	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP2A6—hepatitis B	4.23e-05	0.000747	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—F2—hepatitis B	4.22e-05	0.000746	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—NOS2—hepatitis B	4.17e-05	0.000737	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GGT1—hepatitis B	4.16e-05	0.000735	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GOT1—hepatitis B	4.16e-05	0.000735	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	3.95e-05	0.000697	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—GOT1—hepatitis B	3.95e-05	0.000697	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GOT2—hepatitis B	3.83e-05	0.000676	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	3.79e-05	0.00067	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP2A6—hepatitis B	3.42e-05	0.000605	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GGT1—hepatitis B	3.3e-05	0.000583	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GOT1—hepatitis B	3.3e-05	0.000583	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GOT2—hepatitis B	3.1e-05	0.000547	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	3.01e-05	0.000532	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CCR5—hepatitis B	2.95e-05	0.00052	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—HLA-A—hepatitis B	2.87e-05	0.000507	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—IL2—hepatitis B	2.84e-05	0.000502	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GGT1—hepatitis B	2.67e-05	0.000472	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GOT1—hepatitis B	2.67e-05	0.000472	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NOS2—hepatitis B	2.5e-05	0.000441	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	2.44e-05	0.00043	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—TGFB1—hepatitis B	2.22e-05	0.000392	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ALB—hepatitis B	2.21e-05	0.000391	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CD4—hepatitis B	1.85e-05	0.000327	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—TP53—hepatitis B	1.83e-05	0.000322	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ALB—hepatitis B	1.76e-05	0.00031	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PTEN—hepatitis B	1.69e-05	0.000298	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CTNNB1—hepatitis B	1.64e-05	0.00029	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CDKN1A—hepatitis B	1.6e-05	0.000283	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PTEN—hepatitis B	1.6e-05	0.000283	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PTEN—hepatitis B	1.34e-05	0.000237	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TGFB1—hepatitis B	1.33e-05	0.000234	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PTEN—hepatitis B	1.08e-05	0.000192	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—IL6—hepatitis B	1e-05	0.000177	CbGpPWpGaD
